Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals

被引：45

作者：

Le Monnier, A. ^{[1
]}

Duburcq, A. ^{[2
]}

Zahar, J. -R. ^{[3
]}

Corvec, S. ^{[4
]}

Guillard, T. ^{[5
]}

Cattoir, V. ^{[6
]}

Woerther, P. -L. ^{[7
]}

Fihman, V. ^{[8
]}

Lalande, V. ^{[9
]}

Jacquier, H. ^{[10
]}

Mizrahi, A. ^{[1
]}

Farfour, E. ^{[11
]}

Morand, P. ^{[12
]}

Marcade, G. ^{[13
]}

Coulomb, S.

Torreton, E. ^{[2
]}

Fagnani, F. ^{[2
]}

Barbut, F. ^{[14
]}

机构：

[1] GH Paris St Joseph, Lab Microbiol Clin, Paris, France

[2] CEMKA EVAL, Bourg La Reine, France

[3] Univ Paris 05, Lab Microbiol Hyg, Sorbonne Paris Cite, Hop Necker Enfants Malades,AP HP, Paris, France

[4] CHU Nantes, Serv Bacteriol Hyg Hosp, Nantes, France

[5] Univ Reims, Lab Bacteriol Virol Hyg Hosp, CHU Reims, Hop Robert Debre, Champagne Ardenne, France

[6] CHU Caen, Microbiol Serv, F-14000 Caen, France

[7] Inst Gustave Roussy, Lab Microbiol, Villejuif, France

[8] CHU Henri Mondor, Unite Bacteriol Hyg, F-94010 Creteil, France

[9] Hop St Antoine, AP HP, Hop Univ Est Parisien, Dept Bacteriol, Paris, France

[10] Grp Hosp Lariboisiere Fernand Widal, AP HP, Lab Microbiol, Paris, France

[11] Ctr Hosp Versailles, Lab Microbiol, Le Chesnay, France

[12] Univ Paris 05, Serv Bacteriol, Sorbonne Paris Cite, Hop Cochin, Paris, France

[13] Hop Univ Paris Nord Val de Seine, AP HP, Serv Bacterool Hyg, Hop Louis Mourier, Colombes, France

[14] CHU St Antoine, Lab Clostridium Difficile Associe CNR Bacteries A, St Antoine, France

来源：

JOURNAL OF HOSPITAL INFECTION | 2015年 / 91卷 / 02期

关键词：

Case-control study; Clostridium difficile infection; Costs analysis; Recurrence; CLINICAL MICROBIOLOGY; EUROPEAN-SOCIETY; ECONOMIC BURDEN; SPREAD; FRANCE; STAY;

D O I：

10.1016/j.jhin.2015.06.017

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Background: The impact of Clostridium difficile infection (CDI) on healthcare costs is significant due to the extra costs of associated inpatient care. However, the specific contribution of recurrences has rarely been studied. Aim: The aim of this study was to estimate the hospital costs of CDI and the fraction attributable to recurrences in French acute-care hospitals. Methods: A retrospective study was performed for 2011 on a sample of 12 large acute-care hospitals. CDI costs were estimated from both hospital and public insurance perspectives. For each stay, CDI additional costs were estimated by comparison to controls without CDI extracted from the national DRG (diagnosis-related group) database and matched on DRG, age and sex. When CDI was the primary diagnosis, the full cost of stay was used. Findings: A total of 1067 bacteriological cases of CDI were identified corresponding to 979 stays involving 906 different patients. Recurrence(s) were identified in 118 (12%) of these stays with 51.7% of them having occurred within the same stay as the index episode. Their mean length of stay was 63.8 days compared to 25.1 days for stays with an index case only. The mean extra cost per stay with CDI was estimated at (sic)9,575 (median: (sic)7,514). The extra cost of CDI in public acute-care hospitals was extrapolated to (sic)163.1 million at the national level, of which 12.5% was attributable to recurrences. Conclusion: The economic burden of CDI is substantial and directly impacts healthcare systems in France. (C) 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

引用

页码：117 / 122

页数：6

共 24 条

[1]

[Anonymous], 20 EUR C CLIN MICR I

[2]

Barbut Frederic, 2015, Presse Med, V44, pe75, DOI 10.1016/j.lpm.2014.09.021

[3] European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) [J].

Bauer, M. P. ;

Kuijper, E. J. ;

van Dissel, J. T. .

CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) :1067-1079

[4] Clostridium difficile infection in Europe: a hospital-based survey [J].

Bauer, Martijn P. ;

Notermans, Daan W. ;

van Benthem, Birgit H. B. ;

Brazier, Jon S. ;

Wilcox, Mark H. ;

Rupnik, Maja ;

Monnet, Dominique L. ;

van Dissel, Jaap T. ;

Kuijper, Ed J. .

LANCET, 2011, 377 (9759) :63-73

[5] Clostridium difficile Infection in the Republic of Ireland: Results of a 1-Month National Surveillance and Ribotyping Project, March 2009 [J].

Burns, Karen ;

Skally, Mairead ;

Solomon, Katie ;

Scott, Louise ;

McDermott, Sinead ;

O'Flanagan, Darina ;

Fanning, Seamus ;

Kyne, Lorraine ;

Fenelon, Lynda ;

Fitzpatrick, Fidelma .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (10) :1085-1087

[6] Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial [J].

Cornely, Oliver A. ;

Crook, Derrick W. ;

Esposito, Roberto ;

Poirier, Andre ;

Somero, Michael S. ;

Weiss, Karl ;

Sears, Pamela ;

Gorbach, Sherwood .

LANCET INFECTIOUS DISEASES, 2012, 12 (04) :281-289

[7] European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI) [J].

Crobach, M. J. T. ;

Dekkers, O. M. ;

Wilcox, M. H. ;

Kuijper, E. J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) :1053-1066

[8] Attributable Inpatient Costs of Recurrent Clostridium difficile Infections [J].

Dubberke, Erik R. ;

Schaefer, Eric ;

Reske, Kimberly A. ;

Zilberberg, Marya ;

Hollenbeak, Christopher S. ;

Olsen, Margaret A. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (11) :1400-1407

[9] Burden of Clostridium difficile on the Healthcare System [J].

Dubberke, Erik R. ;

Olsen, Margaret A. .

CLINICAL INFECTIOUS DISEASES, 2012, 55 :S88-S92

[10] Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey [J].

Eckert, C. ;

Coignard, B. ;

Hebert, M. ;

Tarnaud, C. ;

Tessier, C. ;

Lemire, A. ;

Burghoffer, B. ;

Noel, D. ;

Barbut, F. .

MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (02) :67-74

← 1 2 3 →